In young infants under 3 months old, Goenka et al. described that strong functional antibody responses (high anti-spike IgG levels in sera and saliva) combined with tempered IFN-γ production may effectively protect infants from severe COVID-19 complications [96]. This evidence concerns the gene IFNG and COVID-19.